Maria Braoudaki

Dr. Maria Braoudaki is a Reader in Molecular Medicine at the University of Hertfordshire, UK. She holds a PhD in Molecular Microbiology from Aston University (2004) and an MSc in Molecular Medicine (with distinction) from the National and Kapodistrian University of Athens. Her research focuses on pediatric cancer genomics, epigenetics, and proteomics, with emphasis on microRNA profiling and high-throughput omics strategies. She has authored over 40 peer-reviewed publications and received prestigious awards, including the L’OREAL-UNESCO Award for Women in Science (2016) and recognition from the Cretan Scientists Association (2022).

Research Projects:

• Cancer Management using AI (Co-Investigator, 2022–present)
• Apafix fixation for tissue analysis (Principal Investigator, 2022)

Research Interests:

• MicroRNA-driven therapeutic strategies in pediatric and adult cancers
• Epigenetic regulation in oncogenesis
• Omics-based approaches for cancer diagnosis and prognosis

Key Contributions:

• Pioneered work on microRNA signatures in medulloblastoma and glioblastoma
• Developed novel biomarker strategies for lung and colorectal cancers
• Explored extracellular vesicles as therapeutic delivery systems

Grants & Collaborations:

• Lead investigator in Apafix fixation studies
• Co-Investigator in AI-driven cancer recurrence prediction (CaRPrAI, 2021–2022)